Zimbabwe has declined a substantial American healthcare agreement valued at 367 million US dollars (272 million pounds) over five years due to Washington's insistence on sensitive information.
This rejection became public after a internal memorandum from December was leaked, indicating that President Emmerson Mnangagwa deemed the deal was "unbalanced".
A government spokesperson has since explained that the United States was requesting biological samples for research and profit while was not willing to guarantee the benefits from future treatments.
"We will now turn to the difficult and regrettable process of scaling back our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the US had donated over $1.9bn for health programmes to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has appealed for continued dialogue to find a agreement suitable to both sides so the nation's vital HIV treatment initiative can be sustained.
Broader Context
This rejection comes after a similar situation in Kenya, where a high court suspended a related deal with the US after legal challenges were filed about the security of Kenyans' health data.
Since returning to the presidency recently, US President Donald Trump has drastically cut overseas assistance and closed the US Agency for International Development (USAID).
USAID had administered aid for the US government, but Trump claimed its expenditure was "inefficient" and his government was pursuing direct bilateral deals to enhance transparency and responsibility.
According to statements, Sixteen nations in Africa have to date agreed to these new agreements, representing over $18.3bn of fresh investment.
Specifics of the Rejected Deal
This assistance for Zimbabwe would have supported "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this cooperation could have provided immense advantages for the people of Zimbabwe, especially the 1.2 million currently on HIV treatment through American-funded programmes," Tremont added.
However, government spokesperson Nick Mangwana argued the proposed deal was "unfair".
"Our nation was requested to share its genetic material and health information indefinitely, with no equivalent guarantee of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that shared data," he stated.
"In essence, our country would supply the basic resources for scientific discovery without any certainty that the resulting innovations would be accessible to our people should a future pandemic arise."
Sovereignty and Global Health
He also said that the US's withdrawal from the global health body and its pursuit of bilateral health agreements were undermining systems already set up via the global health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing framework created to manage potential global health emergencies.
"This system is designed to guarantee that when a country provides its information, the benefits – such as medicines and cures – are distributed fairly, not commercialised solely by those with the resources to develop them."
Zimbabwe's reservations over the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We encourage further dialogue with our American counterparts on how future co-operation could be structured in a manner that honours the independence and dignity of both nations."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it recognised the government's concerns, but urged that talks should continue since a large portion of the country's Aids initiatives were funded by external financing.
"Where specific concerns arise, such as those involving information security or implementation frameworks, these can frequently be resolved via technical clarification and negotiated safeguards," the group commented.
The situation emphasises the ongoing tensions between accepting vital international aid and safeguarding a country's data in an increasingly interconnected world.